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Three putative processing enzymes, each with defined action in a prohormone system, a ‘pro-ocytocin-neurophysin con- 
vertase’ from bovine neurohypophysis secretory granules, a ‘Leu-enkephalin Arg6 generating enzyme’ from human CSF 
and the endoprotease from the ‘S-28 convertase’ complex of rat brain cortex, were tested for their ability to hydrolyze 
peptides deriving from pro-ocytocin, pro-enkephalin B and pro-somatostatin, respectively at pairs of basic amino acids. 
The observations suggest that structural parameters specified by the peptide region around the dibasic moieties govern 
recognition by the enzyme and define which peptide bond is hydrolyzed. 
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1. INTRODUCTION 
Bioactive peptides are released from biosyn- 
thetic precursors, the prohormones, in which the 
peptide sequences are typically flanked by pairs of 
basic amino acids. Endoproteases, known as pro- 
cessing enzymes, act at these pairs and the remain- 
ing basic NHz- or COOH-terminal amino acid is 
removed by an exopeptidase [1,2]. Closer in- 
vestigation of such endoproteases reveals that they 
exhibit, in a number of cases, a marked selectivity 
[3-IO]. Previous work has indicated that in a fami- 
ly of similar peptide substrates, the same peptide 
bond is cleaved by a given endoprotease; i.e. either 
in between the dibasic pair for the pro-enkephalin 
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B derived substrates [3-51, on the COOH-terminal 
side of the doublet in the case of pro-alpha-mating 
factor [6], pro-ocytocin/neurophysin (pro- 
OT/Np) [7,8] processing enzyme, or else the 
NHz-terminal side of the Arg-Lys doublet in the 
case of somatostatin-28 [9]. Preliminary examina- 
tion of the observations made in various 
laboratories, suggested that the peptide substrate 
conformation may play an important role in the 
specification of the cleavage loci [11,12] and that 
the interactions between the lateral domains of the 
constituting amino acids of a substrate and the ap- 
propriate subsites of the peptidase mainly govern 
the selection of the peptide bond involved in the 
hydrolytic process. 
In order to test such a hypothesis, a comparative 
study was conducted using three highly purified 
putative processing enzymes and corresponding 
natural or synthetic substrates. 
2. MATERIALS AND METHODS 
2.1. Enzyme preparations 
Pro-OT/Np convertase was prepared from bovine 
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neurohypophysis secretory granules as described previously [7]. 
The highly purified preparation was obtained after the isoelec- 
tric focusing step 18). The endoprotease from S-28 convertase 
was extracted from rat brain cortices as previously described 
[13]. The purified fraction was recovered after ion-exchange 
chromatography on DEAE Sephadex [9] and further purified 
by HPLC on a TSK G-3000 SW column [14]. The Leu- 
enkephalin-Arg6 generating protease activity was fractionated 
from human CSF on a tandem column system using DEAE 
Sepharose and phenyl-Sepharose chromatography followed by 
a Sephadex G- 100 filtration [4]. 
2.2. Peptide substrates 
Somatostatins-14 and -28 (S-14 and S-28) were purchased 
from Bachem (Bubendorf, Switzerland) and dynorphin B (dyn 
B), Leu-enkephalin, Leu-enkephalin-Arg6 were from Peninsula 
(S. Carlos, CA, USA). In all cases, their purity was tested by 
HPLC using different buffer systems. 
The following peptides were synthesized in the laboratory by 
the solid-phase method [12,15]. They were identified by amino 
acid composition, NH*-terminal sequencing, FAB mass spec- 
trometry, HPLC and TLC. 
Scheme 1. 
2.3. Enzyme assays 
In each case, 20 pg of either pro OT/Np(l d20) or dynor- 
phin B or 5 gg of hypothalamic S-28 were incubated according 
to the following procedures. 
2.3.1. pro-OT/Np convertase 
With 75 pl of enzyme preparation (2 pg of protein) for 24 h 
in a final volume of 100 pl in 50 mM ammonium acetate buffer, 
pH 7.0, at 37°C. 
2.3.2. S-28 convertase/endoprotease 
With IO pl of the purified enzyme (125 ng protein) in a final 
volume of IOOpl in 0.2 M Tris-HCI buffer, pH 7.2, for 10 h, 
at 31°C. 
2.3.3. Leu-enkephalin Arg6 generating activity 
With 25 pl of endoprotease (5 pg protein) in a final volume 
of 200~1 in 0.2 M Tris-HCI buffer at pH 7.2 for 13 h, at 37°C. 
The enzyme reaction was stopped by acidification of the 
medium followed by evaporation with a vacuum centrifuge. 
The resulting mixture was then analyzed by HPLC and the pep- 
tides generated were identified by a combination of (i) their 
retention time relative to standards; (ii) amino acid composi- 
tion; (iii) NHr-terminal sequencing of the four first amino 
acids; (iv) and in the case of both enkephalin and somatostatin 
related peptides, by a specific radioimmunoassay. 
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Fig.1 HPLC analysis of the endoprotease reaction mixtures. 
Leu-enkephalin-Argo generating enzyme (B), endoprotease 
from S-28 convertase complex (C), and pro-OT/Np convertase 
(D), were incubated with: dynorphin B (1), pro- 
OT/Np(2-20) (2) and somatostatin-28 (3), as described in 
section 2. Line (A) represents the elution profiles of the 
substrates incubated in the absence of enzyme activities. The 
respective retention times for: dynorphin B (77+ 13) (a), Leu- 
enkephalin-Arg6 (b), Leu-enkephalin (c), OTGlyLysArg (d), 
OTGIyLys (e), OTGly (f), pro-OT/Np(l3+20) (g), 
Arg-‘Lys-‘-somatostatin-14 (h), Lyss-somatostatin-14 (i) and 
somatostatin-14 (j) are indicated by arrows. 
2.4. Radioimmunoassay 
Somatostatin-like material was evaluated quantitatively using 
RIA with anti-somatostatin antiserum 36-38 [13]. Enkephalin 
related peptides were evaluated using a previously described 
RIA [16]. 
2.5. Amino acid sequencing and analysis 
Amino acid composition was established by derivatization of 
the hydrolyzed samples with DABSCl which were further 
separated by HPLC [17]. NHZ-terminal sequencing was per- 
formed using the DABITCIPITC double coupling method, and 
the derivatives were identified by a bi-dimensional 
chromatography system [18]. 
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Table 1 
Schematic representation of the peptide bond in the substrate hydrolyzed by 
various endopeptidases 
Enzyme Substrate 
Dynorphin B pro-OT/Np(l-20) Somatostatin-28 
Leu-enkephalin- -ARG-ARG- -LYS-ARG- -ARG-LY S- 
A& generating r t t 
S-28 convertase -ARG-ARG- 0 -ARG-LY S- 
(endopeptidase) t t 
pro-OT/Np 0 -LYS-ARG- 0 
convertase t 
The arrow indicates the peptide bond hydrolyzed. 0 means no reaction (i.e. 
unmodified substrate was recovered). Dynorphin B is: Tyr’GlyGlyPheLeuArg- 
ArgGlnPheLysValValThr”. Somatostatin-28 is: Ser’AlaAsnSerAsnProAla- 
MetAlaProArgGluArgLysAlaGlyCysLysAsnPhePheTrpLysThrPheThrSer- 
I I 
Cy?. pro-OT/Np(l--r20) is: Cys’TyrlleGlnAsnCysProLeuGlyGlyLysArg- 
AlaValLeuAspLeuAspValArg” 
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2.6. High-pressure liquid chromatography 
Somatostatin-like material was eluted by an isocratic gradient 
made of 25% acetonitrile in 0.1 M triethylamine phosphate, pH 
3.0, from a p-Bondapack C-18 column. The OT/Np material 
was eluted by an isocratic system of 20% acetonitrile in 0.05% 
trifluoroacetic acid from the same column. The pro-enkephalin 
B derived peptides were analyzed on a column TSK ODS-120T 
(LKB, Uppsala, Sweden) with a linear gradient from 15% to 
45% acetonitrile containing 0.04% trifluoroacetic acid, in 
30 min. 
3. RESULTS 
The highly purified enzyme preparations were 
incubated with three different substrates: S-28, 
dyn-B and pro-OT/Np( l-20). The peptides 
generated by the reaction with the endoproteases 
pro-OT/Np convertase, Leu-enkephalin-Arg6 
generating activity, and the one implicated in S-28 
convertase respectively were analyzed by HPLC 
(fig.1). Analysis of the results led to the following 
observations: (i) the ‘Leu-enkephalin-Arg6 
generating activity’ cleaves the three substrates; (ii) 
the endopeptidase involved in the ‘S-28 convertase’ 
complex cleaves S-28 and dyn B; and (iii) the ‘pro- 
OT/Np convertase’ cleaves only its own substrate, 
i.e. pro-OT/Np(l-20). In all cases the peptide 
generated after enzyme incubation is the product 
of hydrolysis of a unique peptide bond around the 
cleavage site (i.e. either, before, in between or after 
the pair of basic amino acids). These results in- 
dicate that in the case where enzymes recognize 
only pairs of basic amino acids, their specificity for 
the substrate differs from one enzyme to the other. 
Interestingly, the endoproteases ‘Leu-enkephalin- 
Arg6 converting activity’ and the one implicated in 
‘S-28 convertase’ hydrolyze different peptide 
bonds in the various substrates. 
Indeed, the endoprotease from ‘S-28 convertase’ 
which was demonstrated to cleave S-28 before the 
ArgLys doublet, generating the intermediate 
[Arg-‘Lys-‘lsomatostatin-14, produces from dyn 
B the peptide Leu-enkephalin-Arg6 by cleaving in 
between the ArgArg doublet. The ‘Leu- 
enkephalin-Arg6 generating activity’ which 
hydrolyzes the peptide bond situated in between 
the ArgArg doublet, generates the product 
OTGlyLysArg from pro-OT/Np( l-20) by 
hydrolysis of the peptide bond situated after the 
cleavage site. In all cases, no secondary cleavage 
reaction was detected and in the case where no 
cleavage was observed (table 1) the original peptide 
substrate was recovered unchanged after the reac- 
tion. Table 1 summarizes these results in a 
schematic way. 
4. DISCUSSION 
It is now clear fhat two different types of pro- 
teases have to be involved in the excision of peptide 
hormones from their precursors. Indeed, in order 
to account for the selective release of bioactive 
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fragments from their pro-forms, both an en- 
doprotease and exopeptidase(s) must participate in 
the removal of the remaining basic amino acids on 
either the NH2- or COOH-termini. There is also 
evidence for the presence of these enzyme species 
[19,20] in the secretory organelles. At this time 
their relevance to the in vivo process has not, as 
yet, been unequivocally established except for 
KEX2, KEXr and STEr3 gene products in yeast 
[21]. Although in the case of these two gene 
products the enzyme material was alleged to be 
segregated in distinct secretory compartments 
(Fuller, R.S. et al., unpublished), other examples 
suggest co-localization of these components 
[19,20]. 
It is known that polyenzyme complexes may 
favor regulatory processes, and that in the case of 
proneuropeptide maturation, obviously, the en- 
doprotease specificity and mode of peptide bond 
cleavage both define the nature of exopeptidase(s) 
necessarily involved in the subsequent steps (see 
Discussion in [1,2]). The reported data strongly 
suggest that endoprotease selectivity is both 
specified by the basic doublet and by the nature of 
the subsites surrounding the catalytic site. The 
known specificity for basic amino acids of these 
proteases hows that binding sites involved in the 
recognition of both Lys and/or Arg side chain are 
necessary. The nature of the peptide bond to be 
cleaved should be determined, therefore by struc- 
tural contacts with enzyme subsites ituated either 
on the NH2- or COOH-side of the basic pair of the 
substrate (Sn and Sn’ subsites, respectively). These 
are not as yet fully characterized. The use of selec- 
tively modified substrates may prove useful in a 
more precise definition of the conformational 
parameters underlying these interactions [ 121. 
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